Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Stemcell Holdings Total Liabilities (Quarterly): 6.023M for Sept. 30, 2018
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 6.023M |
| June 30, 2018 | 4.798M |
| March 31, 2018 | 3.326M |
| December 31, 2017 | 2.610M |
| September 30, 2017 | 2.647M |
| Date | Value |
|---|---|
| June 30, 2017 | 3.020M |
| March 31, 2017 | 1.446M |
| December 31, 2016 | 1.868M |
| September 30, 2016 | 1.417M |
| June 30, 2016 | 0.1792M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Electromed Inc | 6.622M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.03M |
| Shareholders Equity (Quarterly) | 6.009M |